Hide metadata

dc.date.accessioned2013-03-12T12:12:58Z
dc.date.available2013-03-12T12:12:58Z
dc.date.issued2012en_US
dc.date.submitted2013-02-04en_US
dc.identifier.citationBorgan, Eldrid. Transcriptomics and metabolomics of breast cancer to improve the understanding of disease mechanisms and treatment response. Doktoravhandling, University of Oslo, 2012en_US
dc.identifier.urihttp://hdl.handle.net/10852/34623
dc.language.isoengen_US
dc.relation.haspartPaper I Borgan E, Navon R, Moen Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Molecular Oncology 2011. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1016/j.molonc.2011.08.004
dc.relation.haspartPaper II Borgan E, Sitter B, Lingjærde OC, Johnsen H, Lundgren S, Bathen TF, Sørlie T, Børresen-Dale AL, Gribbestad IS Merging transcriptomics and metabolomics- advances in breast cancer profiling. BMC Cancer 2010, 10: 628. Published under the terms of the Creative Commons Attribution License. The published version of this paper is available at: https://doi.org/10.1186/1471-2407-10-628
dc.relation.haspartPaper III Moestue SA, Borgan E, Huuse E, Lindholm E, Sitter B, Børresen-Dale AL, Engebråten O, Mælandsmo G, Gribbestad IS Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer 2010, 10: 433. Published under the terms of the Creative Commons Attribution License. The published version of this paper is available at: https://doi.org/10.1186/1471-2407-10-433
dc.relation.haspartPaper IV Borgan E, Lindholm EM, Moestue SA, Mælandsmo GM, Lingjærde OC, Gribbestad IS, Børresen-Dale AL, Engebraaten O, Sørlie T Metabolomic and transcriptomic response to bevacizumab and doxorubicin in basal-like and luminal-like breast cancer xenograft models. Manuscript. Published as: Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts. Mol Oncol. 2013 Feb;7(1):130-42. The published version of this paper is available at: https://doi.org/10.1016/j.molonc.2012.10.005
dc.relation.urihttps://doi.org/10.1016/j.molonc.2011.08.004
dc.relation.urihttps://doi.org/10.1186/1471-2407-10-628
dc.relation.urihttps://doi.org/10.1186/1471-2407-10-433
dc.relation.urihttps://doi.org/10.1016/j.molonc.2012.10.005
dc.titleTranscriptomics and metabolomics of breast cancer to improve the understanding of disease mechanisms and treatment responseen_US
dc.typeDoctoral thesisen_US
dc.date.updated2013-02-05en_US
dc.creator.authorBorgan, Eldriden_US
dc.subject.nsiVDP::700en_US
cristin.unitcode130000en_US
cristin.unitnameMedisinske fakulteten_US
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft.au=Borgan, Eldrid&rft.title=Transcriptomics and metabolomics of breast cancer to improve the understanding of disease mechanisms and treatment response&rft.inst=University of Oslo&rft.date=2012&rft.degree=Doktoravhandlingen_US
dc.identifier.urnURN:NBN:no-33349en_US
dc.type.documentDoktoravhandlingen_US
dc.identifier.duo175864en_US
dc.contributor.supervisorTherese Sørlieen_US
dc.identifier.bibsys130585483en_US
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/34623/1/dravhandling-borgan.pdf


Files in this item

Appears in the following Collection

Hide metadata